Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 609 Carboplatin 373 Paclitaxel 283 Cisplatin 267 Gemcitabine 257 Pemetrexed 194 Nivolumab 192 Bevacizumab 191 Docetaxel 190 Injections 167 Cyclophosphamide 147 atezolizumab 137 Capecitabine 134 Fluorouracil 133 Oxaliplatin 132 Dexamethasone 130 Fulvestrant 115 durvalumab 114 130-nm albumin-bound paclitaxel 110 fludarabine 100 Cetuximab 100 Rituximab 96 Leucovorin 96 venetoclax 89 Lenalidomide 84 enzalutamide 79 Prednisone 79 Ipilimumab 75 Azacitidine 75 Irinotecan 74

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × empagliflozin × 1 year × Clear all

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡